Related Experiment Video

Updated: Jun 6, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

Chronic hepatitis C, insulin resistance and vascular disease

Andreja Trpkovic1, Edith Stokic, Djordje Radak

  • 1Institute Vinca Laboratory for Molecular Genetics and Radiobiology, PO Box 522 11001 Belgrade Serbia.

Current Pharmaceutical Design
|December 7, 2010
PubMed

Insights

Insulin resistance (IR) in chronic hepatitis C (CHC) patients may drive vascular disease and impact antiviral treatment. Insulin-sensitizing agents may improve treatment response and prevent complications.

Area of Science:

  • Hepatology
  • Cardiology
  • Virology

Background:

  • The link between hepatitis C virus (HCV) infection and vascular disease is debated.
  • Insulin resistance (IR) is a known cardiovascular disease (CVD) risk factor and is linked to chronic hepatitis C (CHC).
  • IR may contribute to atherosclerosis and vascular issues in CHC patients.

Purpose of the Study:

  • To review the influence of IR on interferon-alpha (IFN-α) based therapy for HCV.
  • To examine the role of insulin-sensitizing agents in improving antiviral treatment outcomes.
  • To explore the prevention of IR-related complications, such as vascular disease.

Main Methods:

  • Literature review of studies on HCV, IR, and vascular disease.
  • Analysis of the impact of IR on interferon-alpha based therapies.
  • Evaluation of the efficacy of insulin-sensitizing agents in CHC management.

Main Results:

  • HCV-associated IR may promote atherosclerosis and hepatic steatosis.
  • IR can reduce the effectiveness of antiviral treatments.
  • HCV might have direct proatherogenetic effects on the vascular wall.

Conclusions:

  • IR is a significant factor in CHC, affecting both vascular health and treatment efficacy.
  • Insulin-sensitizing agents show potential in managing IR complications and enhancing antiviral responses.
  • Further research is needed to fully elucidate the interplay between HCV, IR, and vascular disease.

More Related Videos

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion08:22

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion

Published on: March 20, 2017

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

Related Concept Videos

Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...